Not Cleared Direct

DEN210049 - Medline ART Skin Harvesting System (FDA 510(k) Clearance)

Mar 2024
Decision
890d
Days
Class 2
Risk

DEN210049 is an FDA 510(k) submission for the Medline ART Skin Harvesting System. This device is classified as a Semi-automated Autologous Skin Graft Harvesting And Application Device (Class II - Special Controls, product code QYK).

Submitted by Medline Industries, Inc. (Northfiled, US). The FDA issued a Not Cleared (DENG) decision on March 27, 2024.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4795. A Semi- Automated Autologous Skin Graft Harvesting And Application Device Is A Handheld Electromechanical Surgical Instrument That Extracts Autologous Skin Graft Tissue From A Healthy Donor Skin Site And Deposits It To A Recipient Site. The Device Extraction And Deposition Functions Are Automated And Are Activated By The User. The Device Is Not Intended For Treatment Of Third Degree Burns..

Submission Details

510(k) Number DEN210049 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received October 19, 2021
Decision Date March 27, 2024
Days to Decision 890 days
Submission Type Direct
Review Panel General & Plastic Surgery (SU)
Summary

Device Classification

Product Code QYK — Semi-automated Autologous Skin Graft Harvesting And Application Device
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4795
Definition A Semi- Automated Autologous Skin Graft Harvesting And Application Device Is A Handheld Electromechanical Surgical Instrument That Extracts Autologous Skin Graft Tissue From A Healthy Donor Skin Site And Deposits It To A Recipient Site. The Device Extraction And Deposition Functions Are Automated And Are Activated By The User. The Device Is Not Intended For Treatment Of Third Degree Burns.